Farvatn Venture — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Talus Biotalus.bioin𝕏Jul 2024
Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts.
AI & Machine LearningBiotechDeep TechHealthtechSeattle, US
Alex Federation(Founder)inLindsay Pino(Founder)in
BoardOmri Amirav-Drory(Director)inJ. Seth Strattan(Director)in
Co-investorsFifty YearsFundersClubNFXTwo Bear CapitalY CombinatorBoxOne Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.